BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 26079547)

  • 21. Loss of SMAD4 from colorectal cancer cells promotes CCL15 expression to recruit CCR1+ myeloid cells and facilitate liver metastasis.
    Itatani Y; Kawada K; Fujishita T; Kakizaki F; Hirai H; Matsumoto T; Iwamoto M; Inamoto S; Hatano E; Hasegawa S; Maekawa T; Uemoto S; Sakai Y; Taketo MM
    Gastroenterology; 2013 Nov; 145(5):1064-1075.e11. PubMed ID: 23891973
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A role for human MUC4 mucin gene, the ErbB2 ligand, as a target of TGF-beta in pancreatic carcinogenesis.
    Jonckheere N; Perrais M; Mariette C; Batra SK; Aubert JP; Pigny P; Van Seuningen I
    Oncogene; 2004 Jul; 23(34):5729-38. PubMed ID: 15184872
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SMAD2, SMAD3 and SMAD4 mutations in colorectal cancer.
    Fleming NI; Jorissen RN; Mouradov D; Christie M; Sakthianandeswaren A; Palmieri M; Day F; Li S; Tsui C; Lipton L; Desai J; Jones IT; McLaughlin S; Ward RL; Hawkins NJ; Ruszkiewicz AR; Moore J; Zhu HJ; Mariadason JM; Burgess AW; Busam D; Zhao Q; Strausberg RL; Gibbs P; Sieber OM
    Cancer Res; 2013 Jan; 73(2):725-35. PubMed ID: 23139211
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FHL1 and Smad4 synergistically inhibit vascular endothelial growth factor expression.
    Zhou Z; Lu J; Dou J; Lv Z; Qin X; Lin J
    Mol Med Rep; 2013 Feb; 7(2):649-53. PubMed ID: 23184087
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of the Smad4 C324Y mutation on thyroid cell proliferation.
    D'Inzeo S; Nicolussi A; Nardi F; Coppa A
    Int J Oncol; 2013 Jun; 42(6):1890-6. PubMed ID: 23591524
    [TBL] [Abstract][Full Text] [Related]  

  • 26. No SMAD4 hypermethylation in colorectal cancer.
    Roth S; Laiho P; Salovaara R; Launonen V; Aaltonen LA
    Br J Cancer; 2000 Oct; 83(8):1015-9. PubMed ID: 10993648
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Histone deacetylase 4 mediates SMAD family member 4 deacetylation and induces 5-fluorouracil resistance in breast cancer cells.
    Yu SL; Lee DC; Son JW; Park CG; Lee HY; Kang J
    Oncol Rep; 2013 Sep; 30(3):1293-300. PubMed ID: 23817620
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Smad4 dependency defines two classes of transforming growth factor {beta} (TGF-{beta}) target genes and distinguishes TGF-{beta}-induced epithelial-mesenchymal transition from its antiproliferative and migratory responses.
    Levy L; Hill CS
    Mol Cell Biol; 2005 Sep; 25(18):8108-25. PubMed ID: 16135802
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disruption of cell-type-specific methylation at the Maspin gene promoter is frequently involved in undifferentiated thyroid cancers.
    Ogasawara S; Maesawa C; Yamamoto M; Akiyama Y; Wada K; Fujisawa K; Higuchi T; Tomisawa Y; Sato N; Endo S; Saito K; Masuda T
    Oncogene; 2004 Feb; 23(5):1117-24. PubMed ID: 14743202
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Status of the DPC4 tumor suppressor gene in sporadic colon adenocarcinoma of Croatian patients: identification of a novel somatic mutation.
    Popović Hadzija M; Radosevic S; Kovacević D; Lukac J; Hadzija M; Spaventi R; Pavelić K; Kapitanović S
    Mutat Res; 2004 Apr; 548(1-2):61-73. PubMed ID: 15063137
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transforming growth factor-beta1 decreases epithelial sodium channel functionality in renal collecting duct cells via a Smad4-dependent pathway.
    Chang CT; Hung CC; Chen YC; Yen TH; Wu MS; Yang CW; Phillips A; Tian YC
    Nephrol Dial Transplant; 2008 Apr; 23(4):1126-34. PubMed ID: 18045816
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Alterations of DPC4/SMAD4/MADH4 gene detected in paraffin-embedded tissues of human pancreatic carcinomas].
    Gu LJ; Chen J; Liu TH; Cui QC; Lu ZH; Li L; Gao J
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Apr; 24(2):165-9. PubMed ID: 12905795
    [TBL] [Abstract][Full Text] [Related]  

  • 33. RIZ1 is epigenetically inactivated by promoter hypermethylation in thyroid carcinoma.
    Lal G; Padmanabha L; Smith BJ; Nicholson RM; Howe JR; O'Dorisio MS; Domann FE
    Cancer; 2006 Dec; 107(12):2752-9. PubMed ID: 17103461
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Frequent epigenetic silencing of the CpG island promoter of RASSF1A in thyroid carcinoma.
    Schagdarsurengin U; Gimm O; Hoang-Vu C; Dralle H; Pfeifer GP; Dammann R
    Cancer Res; 2002 Jul; 62(13):3698-701. PubMed ID: 12097277
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lentiviral-mediated Smad4 RNAi induced anti-proliferation by p16 up-regulation and apoptosis by caspase 3 down-regulation in hepatoma SMMC-7721 cells.
    Huang S; Zhang F; Miao L; Zhang H; Fan Z; Wang X; Ji G
    Oncol Rep; 2008 Nov; 20(5):1053-9. PubMed ID: 18949401
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Involvement of Smads in TGFbeta1-induced furin (fur) transcription.
    Blanchette F; Rudd P; Grondin F; Attisano L; Dubois CM
    J Cell Physiol; 2001 Aug; 188(2):264-73. PubMed ID: 11424093
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A germline mutation (A339V) in thyroid transcription factor-1 (TITF-1/NKX2.1) in patients with multinodular goiter and papillary thyroid carcinoma.
    Ngan ES; Lang BH; Liu T; Shum CK; So MT; Lau DK; Leon TY; Cherny SS; Tsai SY; Lo CY; Khoo US; Tam PK; Garcia-Barceló MM
    J Natl Cancer Inst; 2009 Feb; 101(3):162-75. PubMed ID: 19176457
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduced transcription of the Smad4 gene during pulmonary carcinogenesis in idiopathic pulmonary fibrosis.
    Takenaka K; Gemma A; Yoshimura A; Hosoya Y; Nara M; Hosomi Y; Okano T; Kunugi S; Koizumi K; Fukuda Y; Uematsu K; Shimizu K; Kudoh S
    Mol Med Rep; 2009; 2(1):73-80. PubMed ID: 21475793
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biallelic p.R2223H mutation in the thyroglobulin gene causes thyroglobulin retention and severe hypothyroidism with subsequent development of thyroid carcinoma.
    Raef H; Al-Rijjal R; Al-Shehri S; Zou M; Al-Mana H; Baitei EY; Parhar RS; Al-Mohanna FA; Shi Y
    J Clin Endocrinol Metab; 2010 Mar; 95(3):1000-6. PubMed ID: 20089614
    [TBL] [Abstract][Full Text] [Related]  

  • 40. BRAF mutation and RASSF1A expression in thyroid carcinoma of southern Italy.
    Santoro A; Pannone G; Carosi MA; Francesconi A; Pescarmona E; Russo GM; Feola A; Losito S; Franco R; Nappi L; Aquino G; De Rosa G; Di Domenico M; Bufo P
    J Cell Biochem; 2013 May; 114(5):1174-82. PubMed ID: 23192464
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.